In the latest Research Excellence Framework (REF 2014) Barts and The London School of Medicine and Dentistry was placed within the top seven UK institutions in all three Units of Assessment – Clinical Medicine; Public Health, Health Services and Primary Care; and Allied Health Professions, Dentistry, Nursing and Pharmacy.
The School is nationally and internationally recognised for research in these areas, reflected in the £69 million research income in 2015-2016.
With our partner organisations, our fundamental mission is to ensure that that the best possible clinical service is underpinned by the very latest developments in scientific and clinical teaching, training and research.
We have strong links with Cancer Research UK who awarded £12.4 million to renew the status of our Barts Cancer Centre as an official CRUK research centre, while the World Health Organization has recognised our Unit for Social and Community Psychiatry as one of their designated collaborating centres.
Our work with the National Institute for Health Research, the largest national clinical research funder in Europe, includes an award of £6.5 million to establish the NIHR Biomedical Research Centre for cardiovascular research.
Funding from the Wellcome Trust and Medical Research Council helped establish East London Genes & Health, one of the world’s largest community-based genetics studies based in our Centre for Population Genomic Medicine.
Our Centre for inflammation and Therapeutic Innovation (CiTI) works across Queen Mary University of London, Barts Health NHS Trust and other external academic and industrial partners, to establish expertise in bioengineering, nanomedicine and robotics for the development of innovative therapeutic strategies.
With the Dr Hadwen Trust (otherwise known as the Animal Free Research UK), we established the Animal Replacement Centre of Excellence, a joint venture aiming to develop new treatments using non-animal research methods.